Mass. shuts 11 pharmacies following inspections (Update)

February 5, 2013 by Steve Leblanc

(AP)—Massachusetts officials have ordered 11 pharmacies to completely or partially shut down after a series of inspections prompted by a deadly fungal meningitis outbreak.

The outbreak was discovered in Tennessee in September and has killed 45 people and sickened more than 600 nationwide. It was caused by drugs linked to the Framingham-based New England Compounding Center, which produced a contaminated steroid and has since closed.

The unannounced inspections were conducted over the past several months at 40 Massachusetts sterile compounding pharmacies, which custom-mix medications in doses or forms generally not commercially available.

Besides the 11 cease-and-desist orders, public health inspectors cited 21 other pharmacies for minor deficiencies that have since been corrected or are being addressed.

Pharmacies that have been shut down must submit plans and take corrective actions before they can begin producing drugs again.

Explore further: FDA chief seeks new powers to police pharmacies

shares

Related Stories

FDA chief seeks new powers to police pharmacies

November 14, 2012

(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Senate questions pharmacy boards after outbreak

November 19, 2012

(AP)—A Senate committee investigating a deadly outbreak of meningitis wants to know how regulators in all 50 states oversee specialty pharmacies like the one that triggered the illness.

Consumer watchdog asks FDA to revisit compounders

November 29, 2012

(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...

Congress investigating compounding trade group

December 7, 2012

(AP)—House lawmakers are investigating whether the industry group for compounding pharmacies coached the company responsible for a deadly outbreak of meningitis in dealing with regulators.

FDA chief renews push for specialty pharmacy rules

December 19, 2012

(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest ...

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.